|
US6057287A
(en)
|
1994-01-11 |
2000-05-02 |
Dyax Corp. |
Kallikrein-binding "Kunitz domain" proteins and analogues thereof
|
|
US7153829B2
(en)
|
2002-06-07 |
2006-12-26 |
Dyax Corp. |
Kallikrein-inhibitor therapies
|
|
CA2488558C
(en)
|
2002-06-07 |
2013-08-20 |
Dyax Corp. |
Prevention and reduction of blood loss
|
|
ES2709103T3
(es)
|
2002-08-28 |
2019-04-15 |
Dyax Corp |
Métodos para conservar órganos y tejidos
|
|
WO2005032556A1
(en)
|
2003-10-02 |
2005-04-14 |
Elan Pharmaceuticals, Inc. |
Method for reducing pain
|
|
US7235530B2
(en)
|
2004-09-27 |
2007-06-26 |
Dyax Corporation |
Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
|
|
US20060210697A1
(en)
*
|
2005-03-18 |
2006-09-21 |
Mower Thomas E |
Infant formula composition
|
|
US7666448B2
(en)
*
|
2005-03-18 |
2010-02-23 |
Sakura Properties, Llc |
Skin cleansing article
|
|
US20060210496A1
(en)
*
|
2005-03-18 |
2006-09-21 |
Mower Thomas E |
Compositions for skin protection from ultraviolet damage
|
|
US7776365B2
(en)
*
|
2005-03-18 |
2010-08-17 |
Sakura Properties, Llc |
Article with skin protecting and moisturizing compound
|
|
US20060210692A1
(en)
*
|
2005-03-18 |
2006-09-21 |
Mower Thomas E |
Baby food composition
|
|
US20060210688A1
(en)
*
|
2005-03-18 |
2006-09-21 |
Mower Thomas E |
Dehydrated sports drink powder
|
|
US7749545B2
(en)
|
2005-03-18 |
2010-07-06 |
Sakura Properties, Llc |
Fucoidan compositions and methods for dietary and nutritional supplements
|
|
US20070020358A1
(en)
*
|
2005-03-18 |
2007-01-25 |
Mower Thomas E |
Sports drink concentrate
|
|
EP1877968A2
(en)
*
|
2005-04-12 |
2008-01-16 |
Alianna J. Maren |
System and method for evidence accumulation and hypothesis generation
|
|
US8865743B2
(en)
|
2006-01-06 |
2014-10-21 |
Acelrx Pharmaceuticals, Inc. |
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
|
|
US8202535B2
(en)
|
2006-01-06 |
2012-06-19 |
Acelrx Pharmaceuticals, Inc. |
Small-volume oral transmucosal dosage forms
|
|
US8252329B2
(en)
|
2007-01-05 |
2012-08-28 |
Acelrx Pharmaceuticals, Inc. |
Bioadhesive drug formulations for oral transmucosal delivery
|
|
US8535714B2
(en)
|
2006-01-06 |
2013-09-17 |
Acelrx Pharmaceuticals, Inc. |
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
|
|
US20090209480A1
(en)
*
|
2006-01-17 |
2009-08-20 |
The Regents Of The University Of Colorado |
Central administration of stable formulations of therapeutic agents for cns conditions
|
|
US8536445B2
(en)
*
|
2006-06-02 |
2013-09-17 |
Emcore Solar Power, Inc. |
Inverted metamorphic multijunction solar cells
|
|
US20080102097A1
(en)
*
|
2006-10-31 |
2008-05-01 |
Zanella John M |
Device and method for treating osteolysis using a drug depot to deliver an anti-inflammatory agent
|
|
ES2534433T3
(es)
*
|
2007-08-07 |
2015-04-22 |
Acelrx Pharmaceuticals, Inc. |
Composiciones que comprenden sufentanilo y triazolam para sedación y analgesia operatorias utilizando formas farmacéuticas transmucosas orales
|
|
CA2695012A1
(en)
*
|
2007-08-23 |
2009-02-26 |
Genzyme Corporation |
Treatment with kallikrein inhibitors
|
|
US8470360B2
(en)
|
2008-04-18 |
2013-06-25 |
Warsaw Orthopedic, Inc. |
Drug depots having different release profiles for reducing, preventing or treating pain and inflammation
|
|
CN101412752B
(zh)
*
|
2007-12-26 |
2011-12-07 |
杭州诺泰制药技术有限公司 |
齐考诺肽的固相合成方法
|
|
US9072727B2
(en)
|
2008-04-18 |
2015-07-07 |
Warsaw Orthopedic, Inc. |
Alpha adrenergic receptor agonists for treatment of degenerative disc disease
|
|
USRE48948E1
(en)
|
2008-04-18 |
2022-03-01 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable polymer
|
|
US8722079B2
(en)
*
|
2008-04-18 |
2014-05-13 |
Warsaw Orthopedic, Inc. |
Methods for treating conditions such as dystonia and post-stroke spasticity with clonidine
|
|
US9132119B2
(en)
*
|
2008-04-18 |
2015-09-15 |
Medtronic, Inc. |
Clonidine formulation in a polyorthoester carrier
|
|
US8946277B2
(en)
|
2008-04-18 |
2015-02-03 |
Warsaw Orthopedic, Inc. |
Clonidine formulations in a biodegradable polymer carrier
|
|
US20090264489A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedic, Inc. |
Method for Treating Acute Pain with a Formulated Drug Depot in Combination with a Liquid Formulation
|
|
US8889173B2
(en)
*
|
2008-04-18 |
2014-11-18 |
Warsaw Orthopedic, Inc. |
Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
|
|
US9610243B2
(en)
|
2008-04-18 |
2017-04-04 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable polymer
|
|
US20090264477A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedic, Inc., An Indiana Corporation |
Beta adrenergic receptor agonists for treatment of pain and/or inflammation
|
|
US9132085B2
(en)
*
|
2008-04-18 |
2015-09-15 |
Warsaw Orthopedic, Inc. |
Compositions and methods for treating post-operative pain using clonidine and bupivacaine
|
|
US8883768B2
(en)
*
|
2008-04-18 |
2014-11-11 |
Warsaw Orthopedic, Inc. |
Fluocinolone implants to protect against undesirable bone and cartilage destruction
|
|
US8956641B2
(en)
*
|
2008-04-18 |
2015-02-17 |
Warsaw Orthopedic, Inc. |
Alpha adrenergic receptor agonists for treatment of inflammatory diseases
|
|
US20090263489A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedic, Inc. |
Analgesic and anti-inflammatory compositions and methods for reducing, preventing or treating pain and inflammation
|
|
US8420114B2
(en)
*
|
2008-04-18 |
2013-04-16 |
Warsaw Orthopedic, Inc. |
Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation
|
|
US8629172B2
(en)
|
2008-04-18 |
2014-01-14 |
Warsaw Orthopedic, Inc. |
Methods and compositions for treating post-operative pain comprising clonidine
|
|
US8557273B2
(en)
|
2008-04-18 |
2013-10-15 |
Medtronic, Inc. |
Medical devices and methods including polymers having biologically active agents therein
|
|
US20090263451A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedic, Inc. |
Anti-Inflammatory and/or Analgesic Agents for Treatment of Myofascial Pain
|
|
WO2009135258A1
(en)
*
|
2008-05-06 |
2009-11-12 |
Cnsbio Pty Ltd |
Methods and compositions for the management of pain using omega-conotoxins
|
|
AU2009292643B2
(en)
|
2008-09-19 |
2016-02-18 |
Nektar Therapeutics |
Polymer conjugates of therapeutic peptides
|
|
EP2340046A2
(en)
*
|
2008-09-19 |
2011-07-06 |
Nektar Therapeutics |
Polymer conjugates of ziconotide peptides
|
|
US20100098746A1
(en)
*
|
2008-10-20 |
2010-04-22 |
Warsaw Orthopedic, Inc. |
Compositions and methods for treating periodontal disease comprising clonidine, sulindac and/or fluocinolone
|
|
US8945592B2
(en)
*
|
2008-11-21 |
2015-02-03 |
Acelrx Pharmaceuticals, Inc. |
Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
|
|
US8822546B2
(en)
*
|
2008-12-01 |
2014-09-02 |
Medtronic, Inc. |
Flowable pharmaceutical depot
|
|
US8637454B2
(en)
|
2009-01-06 |
2014-01-28 |
Dyax Corp. |
Treatment of mucositis with kallikrein inhibitors
|
|
US20100228097A1
(en)
*
|
2009-03-04 |
2010-09-09 |
Warsaw Orthopedic, Inc. |
Methods and compositions to diagnose pain
|
|
US20100239632A1
(en)
*
|
2009-03-23 |
2010-09-23 |
Warsaw Orthopedic, Inc. |
Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue
|
|
PL387984A1
(pl)
*
|
2009-05-07 |
2010-11-08 |
Instytut Medycyny Doświadczalnej I Klinicznej Im. Mirosława Mossakowskiego Pan |
Nowe kompozycje substancji leczniczych do leczenia bólów przewlekłych
|
|
US8617583B2
(en)
*
|
2009-07-17 |
2013-12-31 |
Warsaw Orthopedic, Inc. |
Alpha adrenergic receptor agonists for prevention or treatment of a hematoma, edema, and/or deep vein thrombosis
|
|
US8231891B2
(en)
*
|
2009-07-31 |
2012-07-31 |
Warsaw Orthopedic, Inc. |
Implantable drug depot for weight control
|
|
US20110091544A1
(en)
*
|
2009-10-16 |
2011-04-21 |
Acelrx Pharmaceuticals, Inc. |
Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting
|
|
US20110097375A1
(en)
|
2009-10-26 |
2011-04-28 |
Warsaw Orthopedic, Inc. |
Formulation for preventing or reducing bleeding at a surgical site
|
|
RS62853B1
(sr)
|
2010-01-06 |
2022-02-28 |
Takeda Pharmaceuticals Co |
Proteini koji vezuju kalikrein plazme
|
|
DE102010053416A1
(de)
|
2010-12-03 |
2012-06-06 |
Friedrich-Schiller-Universität Jena |
Verfahren zur Synthese von Cystein-haltigen Peptiden durch Native Chemische Ligation und/oder Oxidation
|
|
AU2012204202A1
(en)
|
2011-01-06 |
2013-07-11 |
Dyax Corp. |
Plasma kallikrein binding proteins
|
|
JP2013037571A
(ja)
|
2011-08-09 |
2013-02-21 |
Sony Corp |
情報処理装置、情報処理方法、プログラム、及び情報処理システム
|
|
US9180108B2
(en)
|
2011-10-27 |
2015-11-10 |
Medtronic, Inc. |
Baclofen formulations and methods for making same
|
|
US9155734B2
(en)
*
|
2012-03-07 |
2015-10-13 |
Mallinckrodt Llc |
Stability of hydromorphone hydrochloride solutions
|
|
CA2890455A1
(en)
|
2012-12-04 |
2014-06-12 |
Abbvie, Inc. |
Blood-brain barrier (bbb) penetrating dual specific binding proteins
|
|
WO2014116846A2
(en)
|
2013-01-23 |
2014-07-31 |
Abbvie, Inc. |
Methods and compositions for modulating an immune response
|
|
US20140296830A1
(en)
*
|
2013-03-28 |
2014-10-02 |
Jazz Pharmaceuticals, Inc. |
Methods of administering drugs in an implantable multi-chamber pump
|
|
JP6246640B2
(ja)
*
|
2014-03-25 |
2017-12-13 |
京セラ株式会社 |
電子機器
|
|
AU2015235967B2
(en)
|
2014-03-27 |
2020-10-22 |
Takeda Pharmaceutical Company Limited |
Compositions and methods for treatment of diabetic macular edema
|
|
BR102015010089A2
(pt)
*
|
2015-05-04 |
2017-07-18 |
Ministério Da Ciência E Tecnologia |
Process for obtaining a product for prevention, paralysis of care injuries and remineralization of teeth and obtained product
|
|
JP6731044B2
(ja)
|
2015-05-22 |
2020-07-29 |
クレムソン・ユニバーシティ・リサーチ・ファウンデーション |
生物付着の抑止において用いるためのコノトキシンペプチド
|
|
CN116077648A
(zh)
|
2015-12-11 |
2023-05-09 |
武田药品工业株式会社 |
血浆激肽释放酶抑制剂及其治疗遗传性血管性水肿发作的用途
|
|
US11602513B1
(en)
|
2016-07-22 |
2023-03-14 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US11602512B1
(en)
|
2016-07-22 |
2023-03-14 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US11504347B1
(en)
|
2016-07-22 |
2022-11-22 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
UY37341A
(es)
|
2016-07-22 |
2017-11-30 |
Flamel Ireland Ltd |
Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
|
|
US12478604B1
(en)
|
2016-07-22 |
2025-11-25 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US12186296B1
(en)
|
2016-07-22 |
2025-01-07 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US11986451B1
(en)
|
2016-07-22 |
2024-05-21 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US10369157B1
(en)
|
2018-03-29 |
2019-08-06 |
Mfkc 200, Llc |
Multi-agent formulation
|
|
WO2020178695A1
(en)
|
2019-03-01 |
2020-09-10 |
Flamel Ireland Limited |
Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
|
|
MX2022008649A
(es)
|
2020-01-13 |
2022-09-23 |
Takeda Pharmaceuticals Co |
Inhibidores de calicreina plasmatica y sus usos para tratar episodios de angioedema hereditario pediatrico.
|
|
US11583510B1
(en)
|
2022-02-07 |
2023-02-21 |
Flamel Ireland Limited |
Methods of administering gamma hydroxybutyrate formulations after a high-fat meal
|
|
US11779557B1
(en)
|
2022-02-07 |
2023-10-10 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|